Optos, Inc. news

Optos, a Fife based company and a world-leader in the design and manufacturing of advanced retinal imaging technology, has been awarded NHS funding to accelerate the implementation and validation of Artificial Intelligence (AI) to support the early detection of Diabetes related eye-disease into NHS Diabetic Eye Screening practices.

The technology uses a machine learning algorithm to analyse images of the retina to identify the presence or extent of Diabetic Retinopathy (DR) or Diabeti

Optos plc, the leading medical retinal imaging company, part of Nikon Corporation, is pleased to announce the launch of Silverstone at the American Academy of Ophthalmology, San Francisco, CA.

Silverstone is the first of its kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. Silverstone produces a 200° single capture opto

Dunfermline-based Optos, a leading provider of retinal imaging devices, kept its crown at this year’s Optician Awards in Birmingham (30th March), claiming the title of Optical Supplier of the Year for the second time in a row.

Epitomising the excellence of the UK optical community, the awards set the bar for industry standards and recognise outstanding performance, achievement and ability.

Optos, a world-class manufacturer of patient-friendly, ultr

Optos Plc, a subsidiary of Nikon Corporation, Japan, and Amydis, Inc. today announced a clinical alliance focused on the development of an eye test by Amydis to detect Alzheimer’s disease.  Amydis has developed a pipeline of compounds to detect amyloid proteins in the retina to be visualized with Optos’ market-leading optomap ultra-widefield retinal imaging devices to diagnose Alzheimer’s Disease in patients.  

Through this alliance, Optos